We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

214 hedge funds and large institutions have $1.22B invested in Natus Medical Inc in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 54 increasing their positions, 89 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 21

56% more call options, than puts

Call options by funds: $5.78M | Put options by funds: $3.71M

8% more funds holding

Funds holding: 198214 (+16)

3% more capital invested

Capital invested by funds: $1.18B → $1.22B (+$35.2M)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

39% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 89

Holders
214
Holders Change
+16
Holders Change %
+8.08%
% of All Funds
4.85%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
37
Increased
54
Reduced
89
Closed
21
Calls
$5.78M
Puts
$3.71M
Net Calls
+$2.07M
Net Calls Change
+$8.92M
Name Holding Trade Value Shares
Change
Change in
Stake
FWIA
26
Fort Washington Investment Advisors
Ohio
$10.4M +$10.9M +272,900 New
WCM Investment Management
27
WCM Investment Management
California
$10.2M +$8.92M +223,490 +504%
HAM
28
Hillcrest Asset Management
Texas
$9.59M +$12.8K +320 +0.1%
UBS Group
29
UBS Group
Switzerland
$9.11M +$1.91M +47,883 +25%
CI
30
Cambiar Investors
Colorado
$8.97M +$9.37M +234,817 New
Principal Financial Group
31
Principal Financial Group
Iowa
$8.94M -$674K -16,871 -7%
Ameriprise
32
Ameriprise
Minnesota
$8.56M -$543K -13,595 -6%
Stifel Financial
33
Stifel Financial
Missouri
$8.34M -$3.86M -96,564 -31%
BC
34
Broadfin Capital
New York
$7.81M
BCM
35
Beddow Capital Management
Wyoming
$7.77M -$141K -3,530 -2%
JP Morgan Chase
36
JP Morgan Chase
New York
$7.74M +$6.58M +164,797 +436%
Fiera Capital (Canada)
37
Fiera Capital (Canada)
Quebec, Canada
$7.63M -$1.56M -38,951 -16%
Renaissance Technologies
38
Renaissance Technologies
New York
$6.73M +$7.04M +176,245 New
HIMCH
39
Hartford Investment Management Co (HIMCO)
Connecticut
$6.45M +$408K +10,221 +6%
Deutsche Bank
40
Deutsche Bank
Germany
$6.19M +$5.26M +131,730 +435%
Bank of America
41
Bank of America
North Carolina
$6.14M -$3.2M -80,120 -33%
Charles Schwab
42
Charles Schwab
California
$5.72M -$512K -12,821 -8%
Wells Fargo
43
Wells Fargo
California
$5.56M +$1.83M +45,793 +46%
PFC
44
Phocas Financial Corp
California
$5.24M -$231K -5,778 -4%
SO
45
STRS Ohio
Ohio
$4.2M
Goldman Sachs
46
Goldman Sachs
New York
$4.2M +$237K +5,924 +6%
Invesco
47
Invesco
Georgia
$4.03M +$146K +3,659 +4%
Morgan Stanley
48
Morgan Stanley
New York
$3.79M +$1.86M +46,632 +89%
KCM
49
Kennedy Capital Management
Missouri
$3.52M -$13.2K -330 -0.4%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$3.39M +$55.9K +1,400 +2%

NTUS Hedge Fund Activity: Q4 2017 in Review

214 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q4 2017, worth a combined $1.22B — up 3% from $1.18B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new NTUS positions and 21 closed out — a net gain of 16 holders — while 54 added to existing stakes and 89 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $67.6M. The largest seller was Epoch Investment Partners, exiting entirely with an estimated $20.8M sold.

  • 214 institutional investors held Natus Medical Inc (NTUS) as of Q4 2017, up from 198 in Q3 2017.
  • Funds reported $1.22B of Natus Medical Inc stock for Q4 2017, up 3% quarter-over-quarter.
  • 37 funds opened new Natus Medical Inc positions in Q4 2017 and 21 closed out, a net change of +16 holders.
  • The largest Natus Medical Inc buyer in Q4 2017 was Janus Henderson Group, an estimated $67.6M added.
  • The largest Natus Medical Inc seller in Q4 2017 was Epoch Investment Partners, an estimated $20.8M sold.

Based on aggregated 13F filings for Q4 2017.